Uptake and efficacy of trimetrexate (TMQ, 2,4-diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl] quinazoline), a non-classical antifolate in methotrexate-resistant leukemia cells in vitro

This publication has 6 references indexed in Scilit:

• DDMP (2,4-diamino-5-(3′,4′-dichlorophenyl)-methylpyrimidine)
  Cancer Treatment Reviews, 1980
• Correlates of folate analog transport, pharmacokinetics and selective antitumor action
  Pharmacology & Therapeutics, 1980
• 2,4-Diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline (TMQ), a potent non-classical folate antagonist inhibitor—I
  Biochemical Pharmacology, 1979
• A rapid, radiochemical-ligand binding assay for methotrexate
  Analytical Biochemistry, 1976
• ACTIVE-SITE DIRECTED IRREVERSIBLE INHIBITORS OF DIHYDROFOLATE REDUCTASE
  Annals of the New York Academy of Sciences, 1971
• Transport Energetics of the Folic Acid Analogue, Methotrexate, in L1210 Leukemia Cells
  Published by Elsevier ,1969